These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 867002)

  • 21. MOdification of the electrical activity of the human intestine after serotonin and caerulein.
    Labo G; Barbara L; Lanfranchi GA; Bortolotti M; Miglioli M
    Am J Dig Dis; 1972 Apr; 17(4):363-72. PubMed ID: 5019845
    [No Abstract]   [Full Text] [Related]  

  • 22. Segmentation induced by intraluminal fatty acid in isolated guinea-pig duodenum and jejunum.
    Gwynne RM; Thomas EA; Goh SM; Sjövall H; Bornstein JC
    J Physiol; 2004 Apr; 556(Pt 2):557-69. PubMed ID: 14754993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-dependent effects of cholecystokinin-8 on antropyloroduodenal motility, gastrointestinal hormones, appetite, and energy intake in healthy men.
    Brennan IM; Little TJ; Feltrin KL; Smout AJ; Wishart JM; Horowitz M; Feinle-Bisset C
    Am J Physiol Endocrinol Metab; 2008 Dec; 295(6):E1487-94. PubMed ID: 18957613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of midazolam on small bowel motility in humans.
    Castedal M; Björnsson E; Abrahamsson H
    Aliment Pharmacol Ther; 2000 May; 14(5):571-7. PubMed ID: 10792120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of pancreozymin and glucagon on gastro-duodenal motility in normal subjects.
    Stanciu C; Bennett JR
    Rev Med Chir Soc Med Nat Iasi; 1974; 78(3):609-13. PubMed ID: 4453684
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of motilin and cholecystokinin on sphincter of Oddi and duodenal mobility.
    Muller EL; Grace PA; Conter RL; Roslyn JJ; Pitt HA
    Am J Physiol; 1987 Nov; 253(5 Pt 1):G679-83. PubMed ID: 3688230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of cholecystokinin on small intestine.
    Hedner P; Persson H; Rorsman G
    Acta Physiol Scand; 1967 Jun; 70(2):250-4. PubMed ID: 6035852
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of canine interdigestive proximal gastric motility by cholecystokinin octapeptide.
    Schang JC; Kelly KA
    Am J Physiol; 1981 Mar; 240(3):G217-20. PubMed ID: 7212071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholecystokinin octapeptide stimulates phasic and tonic pyloric motility in healthy humans.
    Fraser R; Fone D; Horowitz M; Dent J
    Gut; 1993 Jan; 34(1):33-7. PubMed ID: 8432448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies of the peristalsis-increasing effect of metoclopramid on the small intestine by means of Crosby small intestine biopsy probe].
    Kriedemann E; Gütz HJ
    Radiol Diagn (Berl); 1969; 10(3):323-6. PubMed ID: 5365717
    [No Abstract]   [Full Text] [Related]  

  • 31. Sensitivities of human jejunum, ileum, proximal colon, and gallbladder to cholecystokinin octapeptide.
    Kellow JE; Miller LJ; Phillips SF; Haddad AC; Zinsmeister AR; Charboneau JW
    Am J Physiol; 1987 Mar; 252(3 Pt 1):G345-56. PubMed ID: 3826375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of cholecystokinin on gastric motility in humans.
    Beglinger C
    Ann N Y Acad Sci; 1994 Mar; 713():219-25. PubMed ID: 8185162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ovine model for clear-cut study on the role of cholecystokinin in antral, small intestinal and gallbladder motility.
    Romański KW
    Pol J Pharmacol; 2004; 56(2):247-56. PubMed ID: 15156076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of motilin and octapeptide of cholecystokinin on antral and duodenal myoelectric activity in the interdigestive state and during inhibition by secretin and gastric inhibitory polypeptide.
    Castresana M; Lee KY; Chey WY; Yajima H
    Digestion; 1978; 17(4):300-8. PubMed ID: 669076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Motility of the Roux-en-Y hepaticojejunostomy in asymptomatic patients.
    Le Blanc-Louvry I; Ducrotté P; Manouvrier JL; Peillon C; Testart J; Denis P
    Am J Gastroenterol; 1999 Sep; 94(9):2501-8. PubMed ID: 10484015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of secretin and pancreozymin on intracavitary pressure in the stomach and duodenum, evacuation from the stomach, and the tone of the pyloric sphincter.
    Geller LI; Petrenko VF
    Hum Physiol; 1980; 6(1):64-8. PubMed ID: 7399540
    [No Abstract]   [Full Text] [Related]  

  • 37. [Contraction power and frequency of various segments of the dog intestines in vivo].
    Rinecker H; Brendel W
    Pflugers Arch Gesamte Physiol Menschen Tiere; 1966; 290(2):144-57. PubMed ID: 5233670
    [No Abstract]   [Full Text] [Related]  

  • 38. Pentagastrin induced motility pattern in the human upper gastrointestinal tract is reversed by proglumide.
    Erckenbrecht JF; Caspari J; Wienbeck M
    Gut; 1984 Sep; 25(9):953-6. PubMed ID: 6469080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral and central administration of exogenous urocortin 1 disrupts the fasted motility pattern of the small intestine in rats via the corticotrophin releasing factor receptor 2 and a cholinergic mechanism.
    Yin Y; Dong L; Yin D
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e79-87. PubMed ID: 17944898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine induces contraction in the proximal, but relaxation in the distal rat isolated small intestine.
    Kirschstein T; Dammann F; Klostermann J; Rehberg M; Tokay T; Schubert R; Köhling R
    Neurosci Lett; 2009 Nov; 465(1):21-6. PubMed ID: 19733212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.